pentoxifylline has been researched along with Facial Hemiatrophy in 1 studies
Facial Hemiatrophy: A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vasconcelos Carvalho, M | 1 |
| do Nascimento, GJ | 1 |
| Andrade, E | 1 |
| Andrade, M | 1 |
| Sobral, AP | 1 |
1 review available for pentoxifylline and Facial Hemiatrophy
| Article | Year |
|---|---|
Association of aesthetic and orthodontic treatment in Parry-Romberg syndrome.
Topics: Biocompatible Materials; Combined Modality Therapy; Esthetics; Facial Asymmetry; Facial Dermatoses; | 2010 |